Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Manfred Ahlgrimm"'
Autor:
Vadim Lesan, Ketevani Melivadze, Johannes Hein, Manfred Ahlgrimm, Stefan Schunk, Moritz Bewarder, Konstantinos Christofyllakis, Joerg Thomas Bittenbring, Lorenz Thurner
Publikováno v:
eJHaem, Vol 5, Iss 4, Pp 863-866 (2024)
Abstract Donor‐specific anti‐human leukocyte antigen (HLA) antibodies represent a main cause of primary graft failure specifically in the setting of haploidentical stem cell transplantation. Newer therapy strategies including daratumumab could ov
Externí odkaz:
https://doaj.org/article/74cb23f88fb448ea89f88ae9c42df933
Autor:
Dominic Kaddu-Mulindwa, Lorenz Thurner, Moritz Bewarder, Niels Murawski, Manfred Ahlgrimm, Thorsten Pfuhl, Barbara Gärtner, Sigrun Smola, Stephan Stilgenbauer
Publikováno v:
Infectious Agents and Cancer, Vol 16, Iss 1, Pp 1-4 (2021)
Abstract Due to the worldwide COVID-19 outbreak it is mandatory for health care workers to develop containment strategies. Recently published data showed, that cancer patients might have a higher risk for severe course of the disease. We therefore de
Externí odkaz:
https://doaj.org/article/0eb297c6126a4f2592e24a603d312e69
Autor:
Igor Kos, Benedikt Balensiefer, Sophie Roth, Manfred Ahlgrimm, Martina Sester, Tina Schmidt, Lorenz Thurner, Moritz Bewarder, Robert Bals, Frank Lammert, Stephan Stilgenbauer, Dominic Kaddu-Mulindwa
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Patients with pre-existing comorbidities and immunosuppression are at greater risk for SARS-CoV-2 infection and severe manifestations of COVID-19. This also includes cancer patients, who are shown to have a poor prognosis after infection. Here, we de
Externí odkaz:
https://doaj.org/article/5ceabfd8ff574f20958a9f7f63b07f79
Autor:
Igor Age Kos, Maximilian Kiefer, Katharina Brill, Onur Cetin, Joerg Thomas Bittenbring, Manfred Ahlgrimm, Sigrun Smola, Stefan Lohse, Konstantinos Christofyllakis, Dominic Kaddu-Mulindwa, Frank Neumann, Moritz Bewarder, Lorenz Thurner
Publikováno v:
Expert review of vaccines. 21(11)
Patients with cancer and autoimmune diseases are at higher risk of severe COVID-19. They may not develop protective immune responses following vaccination. We investigated patients' cellular and humoral immune response after two COVID-19 vaccine dose
Autor:
Frank Lammert, Sigrun Smola, Stephan Stilgenbauer, Philipp M. Lepper, Yvonne Bewarder, Andreas Link, Manfred Ahlgrimm, Stefan Wagenpfeil, Marcin Krawczyk, Martina Seiffert, Joerg Thomas Bittenbring, Frank Neumann, Benedikt Balensiefer, Lorenz Thurner, Dominic Kaddu-Mulindwa, Vadim Lesan, Igor Kos, Konstantin Christofyllakis, Torben Rixecker, Moritz Bewarder, Robert Bals
Publikováno v:
European Journal of Immunology
The pathogenesis of autoimmune complications triggered by SARS‐CoV2 has not been completely elucidated. Here, we performed an analysis of the cellular immune status, cell ratios, and monocyte populations of patients with COVID‐19 treated in the i
Autor:
Stephan Stilgenbauer, Moritz Bewarder, Manfred Ahlgrimm, Niels Murawski, Barbara Gärtner, Thorsten Pfuhl, Dominic Kaddu-Mulindwa, Lorenz Thurner, Sigrun Smola
Publikováno v:
Infectious Agents and Cancer, Vol 16, Iss 1, Pp 1-4 (2021)
Infectious Agents and Cancer
Infectious Agents and Cancer
Due to the worldwide COVID-19 outbreak it is mandatory for health care workers to develop containment strategies. Recently published data showed, that cancer patients might have a higher risk for severe course of the disease. We therefore developed a
Autor:
Dominic Kaddu-Mulindwa, Moritz Bewarder, Stephan Stilgenbauer, Lorenz Thurner, Angelika Bick, Konstantinos Christofyllakis, Joerg Thomas Bittenbring, Niels Murawski, Sarah Altmeyer, Vadim Lesan, Manfred Ahlgrimm, Torben Rixecker
Publikováno v:
Bone Marrow Transplantation. 56:195-201
Patients undergoing intensive chemotherapy are usually in need for central venous catheters (CVC). Due to contradictory study results, relation of insertion site and CVC-associated complication rate in these patients is not clear. We therefore retros
Autor:
Moritz Bewarder, Sigrun Smola, Lorenz Thurner, Frank Neumann, Robert Bals, Dominic Kaddu-Mulindwa, Yvonne Bewarder, Vadim Lesan, Andreas Link, Philipp M. Lepper, Benedikt Balensiefer, Joerg Thomas Bittenbring, Frank Lammert, Manfred Ahlgrimm, Torben Rixecker, Stephan Stilgenbauer, Konstantin Christofyllakis, Stefan Wagenpfeil, Marcin Krawczyk, Martina Seiffert, Igor Kos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9009863631bd379e28c36e25723457f
https://doi.org/10.1002/eji.202049163/v2/response1
https://doi.org/10.1002/eji.202049163/v2/response1
Autor:
Sophie Roth, Benedikt Balensiefer, Manfred Ahlgrimm, Stephan Stilgenbauer, Frank Lammert, Tina Schmidt, Lorenz Thurner, Dominic Kaddu-Mulindwa, Moritz Bewarder, Robert Bals, Martina Sester, Igor Kos
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology
Frontiers in Oncology
Patients with pre-existing comorbidities and immunosuppression are at greater risk for SARS-CoV-2 infection and severe manifestations of COVID-19. This also includes cancer patients, who are shown to have a poor prognosis after infection. Here, we de
Autor:
Manfred Ahlgrimm, Frank Neumann, Joerg Thomas Bittenbring, Michael Pfreundschuh, Gerhard Held, Sybille Raudies, Markus Klotz, Sandra Grass, Natalie Fadle, Evi Regitz, Klaus-Dieter Preuss, Karl-Herbert Schäfer, Niels Murwaski
Publikováno v:
Blood. 118:3340-3346
Paratarg-7, a frequent autoantigenic target, and all other autoantigenic targets of human paraproteins molecularly defined to date are hyperphosphorylated in the respective patients compared with healthy controls, suggesting that hyperphosphorylation